Testosterone deficiency, clinically known as male hypogonadism, is a relatively common condition, though its reported prevalence varies significantly depending on the age group and the diagnostic criteria used. While it is often associated with ageing, it is increasingly seen as a systemic health marker. In 2026, clinical data highlights that while nearly all men experience a gradual decline in hormone levels, only a subset develops a symptomatic deficiency that requires medical intervention.
What We Will Cover in This Article
- Prevalence rates across different age groups
- The difference between biochemical and symptomatic deficiency
- The rising incidence in younger men and Gen Z
- Key comorbidities: How obesity and diabetes multiply the risk
- 2026 UK specific statistics and clinical trends
- Why diagnostic thresholds lead to varying statistics
Prevalence by Age: The Gradual Decline
Testosterone levels naturally peak in late adolescence and early adulthood. From age 30 onwards, total testosterone levels typically decline at a rate of approximately 1 percent per year. This gradual shift means that the older a man is, the more likely he is to fall into the deficient range.
- Men in their 40s: Estimated prevalence is around 4 percent to 8 percent.
- Men in their 50s: Prevalence rises to approximately 10 percent to 12 percent.
- Men over 70: Up to 30 percent of men may have testosterone levels below the standard reference range.
- Men over 80: Prevalence can reach as high as 50 percent, although many of these men may remain asymptomatic.
Biochemical vs. Symptomatic Deficiency
A major challenge in quantifying how common low testosterone is lies in the definition of the condition. Clinicians in 2026 distinguish between two states:
- Biochemical Hypogonadism: This refers to having a blood test result below the reference range (typically less than 12 nmol/L or 300 ng/dL) without necessarily experiencing symptoms. This is more common, affecting up to 20 percent of men over 45.
- Symptomatic Testosterone Deficiency: This requires both a low blood test result and the presence of clinical symptoms like low libido, erectile dysfunction, or fatigue. This is less common, affecting approximately 2 percent to 6 percent of the general male population.
The impact of metabolic health
Perhaps the most significant finding in 2026 is that testosterone deficiency is not solely a product of age. It is deeply linked to metabolic health.
- Obesity: Men with a BMI over 30 are twice as likely to have low testosterone. Prevalence in obese men is often cited as high as 40 percent to 50 percent.
- Type 2 Diabetes: Roughly one in three men with Type 2 diabetes has clinical testosterone deficiency.
- Chronic Illness: Conditions such as HIV, chronic kidney disease, and COPD significantly increase the likelihood of developing hormonal imbalances.
Trends in Younger Men and 2026 UK Data
Recent data from 2024 to 2026 suggests that average testosterone levels in younger men, including Gen Z and Millennials, are lower than they were for previous generations at the same age.
In the UK, recent surveys of community dwelling men show that while formal diagnosis remains relatively low at around 5 percent, nearly half of men over 50 report symptoms that have a high likelihood of being linked to testosterone deficiency. This gap suggests that the condition may be significantly under diagnosed due to the non specific nature of symptoms like fatigue and low mood.
To Summarise
Testosterone deficiency is a common condition that affects millions of men worldwide, with its prevalence doubling nearly every decade after the age of 45. While it is a natural consequence of ageing for some, it is increasingly driven by modifiable factors such as obesity and metabolic health. In 2026, the clinical consensus is that while a biochemical decline is frequent, a symptomatic deficiency that impairs quality of life is the primary concern for medical treatment.
If you experience persistent low energy, unexplained weight gain, or a significant decrease in sexual function, seek a clinical review with your GP to investigate the possibility of hypogonadism.
Why do statistics for low testosterone vary so much?
Different studies use different cut off points for what they consider low. Some define it as below 8 nmol/L, while others use 12 nmol/L, which dramatically changes the percentage of men who qualify.
Is it true that modern men have less testosterone than their grandfathers?
Yes. Large scale observational studies indicate a generational decline in testosterone levels, likely due to environmental factors, sedentary lifestyles, and rising obesity rates.
Does everyone with low testosterone need treatment?
No. Clinical guidelines in 2026 recommend treatment only for those who have both low blood levels and symptoms that impact their health or quality of life.
Can you have low testosterone in your 20s?
Yes, though it is rare, affecting about 1 percent. In younger men, it is often due to genetic conditions, pituitary issues, or significant lifestyle stressors.
Does exercise improve these statistics?
Men who engage in 6 to 10 hours of moderate exercise per week generally have higher average testosterone levels than those who are sedentary.
What is the UK NHS healthy range?
While ranges vary by lab, the NHS generally considers a total testosterone level between 8.6 and 29 nmol/L to be the healthy range for men under 50.
Authority Snapshot
This article was written by the MyPatientAdvice clinical team and reviewed by Dr. Stefan Petrov, a UK trained physician with an MBBS and extensive experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He is a specialist in medical education and creating evidence based health content. This information follows 2026 clinical protocols for the assessment of male hormonal health.
